tralokinumab (Pending FDA Approval)

Brand and Other Names:
  • Print

Dosing & Uses

Atopic Dermatitis

Pending FDA approval for treatment of moderate-to-severe atopic dermatitis

Next:

Pharmacology

Mechanism of Action

Immunoglobulin (Ig) G4 monoclonal antibody (mAb) that works by neutralizing interleukin-13 (IL-13) cytokine and inhibiting downstream IL-13 signaling, which plays a role in driving chronic inflammation of atopic dermatitis

Previous
Next:

Images

Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.